POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 69 filers reported holding POSEIDA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59,428 | +26.8% | 24,969 | -6.2% | 0.03% | +25.9% |
| Q2 2023 | $46,850 | +1.1% | 26,619 | +77.0% | 0.03% | +12.5% |
| Q1 2023 | $46,324 | -42.8% | 15,040 | -1.5% | 0.02% | -44.2% |
| Q4 2022 | $80,934 | +37.2% | 15,270 | -2.4% | 0.04% | +38.7% |
| Q3 2022 | $59,000 | -3.3% | 15,650 | -33.0% | 0.03% | +3.3% |
| Q2 2022 | $61,000 | -49.6% | 23,370 | -12.7% | 0.03% | -33.3% |
| Q1 2022 | $121,000 | +68.1% | 26,770 | +152.1% | 0.04% | +87.5% |
| Q4 2021 | $72,000 | 0.0% | 10,620 | +2.7% | 0.02% | -7.7% |
| Q3 2021 | $72,000 | – | 10,345 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 3,567,985 | $8,491,804 | 2.58% |
| Aisling Capital Management LP | 1,043,267 | $2,482,975 | 1.02% |
| Atom Investors LP | 156,168 | $371,680 | 0.08% |
| Pentwater Capital Management LP | 5,975,000 | $14,220,500 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 79,709 | $189,707 | 0.04% |
| Forefront Analytics, LLC | 24,969 | $59,428 | 0.03% |
| Callan Capital, LLC | 76,559 | $182,210 | 0.02% |
| XTX Topco Ltd | 40,782 | $97,061 | 0.02% |
| Advisory Services Network, LLC | 257,271 | $612,305 | 0.02% |
| RBF Capital, LLC | 70,171 | $167,007 | 0.01% |